Concepedia

Mary Anne Dellva

MA

Statistics

Publications

25

Citations

1.6K

H-Index

18

Active since

1996

Affiliations

Eli Lilly (United States)(Current)

Profil Institute for Metabolic Research

Harvard University

Tokyo Women's Medical University

Rainier Clinical Research Center

Mary Anne Dellva is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and psychopharmacology.

Publications per year

1996–2022

25

Publications

25

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

Charles M. Beasley, S.H. Hamilton, A.M. Crawford et al. · European Neuropsychopharmacology · 1997 · 281 citations

, , +9

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

Charles M. Beasley, Mary Anne Dellva, Roy Tamura et al. · The British Journal of Psychiatry · 1999 · 239 citations

, , +17

Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia

Pierre V. Trân, Mary Anne Dellva, G.D. Tollefson et al. · The Journal of Clinical Psychiatry · 1997 · 169 citations

, , +17

Oral olanzapine <i>versus</i> oral haloperidol in the maintenance treatment of schizophrenia and related psychoses

Pierre V. Trân, Mary Anne Dellva, Gary D. Tollefson et al. · The British Journal of Psychiatry · 1998 · 137 citations

, , +15

Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis

Joerg Czekalla, Charles M. Beasley, Mary Anne Dellva et al. · The Journal of Clinical Psychiatry · 2001 · 120 citations

, , +17

1–5 of 25